HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kallmann Syndrome 5
mutation in CHD7
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Disease Context: Research Results
Urogenital Diseases: 126
Urogenital Abnormalities: 76
Disorders of Sex Development: 730
46,XY Disorder of Sex Development: 472
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Female Urogenital Diseases and Pregnancy Complications
Female Urogenital Diseases
Urogenital Abnormalities: 76
Disorders of Sex Development: 730
46,XY Disorder of Sex Development: 472
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Male Urogenital Diseases
Urogenital Abnormalities: 76
Disorders of Sex Development: 730
46,XY Disorder of Sex Development: 472
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
Congenital Abnormalities: 25723
Urogenital Abnormalities: 76
Disorders of Sex Development: 730
46,XY Disorder of Sex Development: 472
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Inborn Genetic Diseases: 11939
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Endocrine System Diseases: 968
Gonadal Disorders: 30
Hypogonadism: 6201
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Disorders of Sex Development: 730
46,XY Disorder of Sex Development: 472
Kallmann Syndrome: 376
Kallmann Syndrome 5: 1
Experts
1.
Simm, P J
: 1 article (04/2006)
2.
Zacharin, M R
: 1 article (04/2006)
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Kallmann Syndrome 5:
1.
Testosterone (Sustanon)
FDA Link
04/01/2006 - "
Of those patients with Kallmann syndrome, 5/19 reported mild depressive symptoms only, all resolving with testosterone replacement.
"